Biodegradation of hepatotoxin (D-Leu1) - microcystin-LR by bacteria in carbon biological filters

A persistência das microcistinas (MCs) em ambientes aquáticos e sua difícil remoção no tratamento convencional de água representam um desafio às companhias de saneamento. Contudo, as MCs são susceptíveis à degradação por bactérias presentes na água, sedimentos e efluentes de esgotos. Neste estudo, avaliou-se a biodegradação de MCs por microrganismos presentes em filtros de carvão com atividade biológica (CAB) e sua identificação filogenética pelo sequenciamento do gene 16S RNA. Foi utilizada uma água de estudo contendo MCs com diferentes composições, acrescida de efluente de filtros CAB. Os resultados demonstraram que as MCs foram biodegradadas por microrganismos presentes no biofilme. Este estudo infere sobre a capacidade de biodegradação de MCs por bactérias presentes em filtros CAB e o possível uso destes microorganismos como alternativa de remoção de MCs no tratamento de água potável.The persistence of MCs in aquatic environments and their difficult removal in the conventional water treatment is a challenge to companies of sanitation. However, the MCs are susceptible to degradation by bacteria present in water, sediment and sewage effluents. In this study, we investigated the biodegradation of MCs by microorganism present in carbon filters with biological activity (BAC) and their phylogenetic identification by sequencing gene 16S RNA. A study of water containing MCs was used, with different compositions, plus a filters BAC effluent. The results showed that of MCs were biodegraded by microorganism present in the biofilm. This study provides the ability to complete biodegradation of MCs by bacteria present in BAC filters and the possible use of these microorganisms as alternative of the removal of MCs in the treatment of drinking wate

Adenoma pleomórfico da glândula submandibular: Pleomorphic adenoma of the submandibular gland

Introdução: O Adenoma Pleomórfico é o mais comum dentre os tumores benignos, desenvolvendo-se em áreas de tecido glandular, apesar de ser uma importante patologia glandular salivar, o acometimento da glândula submandibular não é o mais prevalente, e sim o da glândula parótida, o que acaba por negligenciar tal manifestação. Apresentação do Caso: Paciente com 38 anos, sexo feminino, melanoderma, procurou o serviço de otorrinolaringologia devido aparecimento de nódulo em região cervical há cerca de 04 anos, associado à limitação de movimento, com prejuízo estético há 02 meses. Nega dor. Ao exame físico local, evidenciou-se lesão nodular de consistência firme, unilocular.  À análise histológica, evidenciou ausência de sinais de malignidade. Discussão: O Adenoma Pleomórfico tem crescimento lento, normalmente, perceptível previamente à consulta médica, de anos a meses, apresentando-se de forma muito semelhante a uma linfonodomegalia cervical, indolor e de consistência firme, podendo se manifestar em todas as idades, com predominância entre os 40 e 50 anos, sendo a excisão cirúrgica com margem de segurança seu tratamento de referência, na maioria das vezes, com um excelente prognóstico e baixo índice de recidivas. Conclusão: A evolução lenta é determinante para a percepção atrasada da lesão em questão, e consequentemente, para a necessidade de excisão cirúrgica, para que se tenha um bom prognóstico, além do aumento nas chances de malignização do tumor, o que torna necessário que haja uma maior exploração do tema ao longo da graduação médica, a fim de repercutir na otimização do diagnóstico e tratamento em níveis de saúde menos avançados e mais acessíveis à população em geral

Síndrome de Stickler: Stickler's Syndrome

INTRODUÇÃO: A Síndrome Stickler é uma colagenopatia, rara, hereditária e caráter autossômica dominante, sua incidência é de 1/7500 nascimentos. APRESENTAÇÃO CASO: GPS, sexo masculino, 5 anos, admitido no Hospital das Clínicas de Goiânia, portador de miopia importante e fissura palatina desde o nascimento, queixava-se de baixa acuidade visual há 3meses. Durante a inspeção, foram evidenciados face plana, maxilar curto, olhos proeminentes e pregas epicantais. DISCUSSÃO: A síndrome é caracterizada por um artro-oftalmopatia, ou seja, anormalidades esqueléticas, anomalias orofaciais, perda auditiva, osteoartrite prematura, perda neuro-sensorial,fenda palatina, miopatia grave e cegueira. É classificada de acordo com a mutação em Tipo I, II e III. CONCLUSÃO: Por se tratar de uma síndrome genética rara, é de difícil diagnóstico, necessita de uma análise fenotípica, um quadro clínico favorável e história familiar. Não existe um tratamento curativo. Portanto, quanto mais precoce seu diagnóstico, a intervenção será mais rápida e melhor será o prognóstico

Síndrome de Morgagni-Stewart-Morel: Morgagni-Stewart-Morel syndrome

Introdução: a síndrome de Morgagni Stewart Morel é uma entidade clínica rara. Sua principal característica é a hiperostose frontal interna. Além disso, conta com alterações endócrinas​ metabólicas e psiquiátricas. Pode estar acompanhada de obesidade, diabetes mellitus e hirsutismo. Possui maior prevalência na população feminina. Apresentação do caso: paciente do sexo feminino, 65 anos, obesa em menopausa há 12 anos. Relata em consulta queixa de cefaleia em aperto na região frontal há cerca de 6 anos. A mesma vem se intensificando gradativamente e há 01 semana a dor não é sanada mesmo com o uso de anti-inflamatórios ou analgésicos orais. Discussão: a síndrome de Morgagni-Stewart-Morel consiste em uma condição rara, caracterizada pela presença de Hiperostose Frontal Interna (HFI) associada a alterações metabólicas, psiquiátricas e endócrinas. Sua definição não é uniforme devido a diversidade de sintomas e a sua variabilidade em cada indivíduo. Possui incidência maior no sexo feminino e com idade acima de 50 anos, sua etiologia ainda é pouco conhecida. Algumas teorias buscam elucidar o tema como o aumento da leptina, desordem hormonal de andrógenos e há também defensores de uma síndrome genética, ligada ao X com penetrância variável. Conclusão: diante da raridade de casos da síndrome, o diagnóstico geralmente ocorre de modo incidental, por meio da correlação entre sintomatologia variada e investigação radiológica. Sua abordagem terapêutica é predominantemente sintomática, de modo a se optar por conduta cirúrgica em casos reservados

Avulsão da Espinha Ilíaca anterosuperior pós traumática : Post-traumatic anterosuperior Iliac Spine avulsion

Introdução: As lesões ósseas da pelve e quadril são raras, e ocorrem principalmente na faixa etária de 8 a 14 anos, e estão relacionadas à prática de atividades físicas de alto impacto e repetitivas. As fraturas por avulsão das espinhas ilíacas superior e inferior e tuberosidade isquiática tem maior incidência devido ao aumento da prática de desportos nessa faixa etária. Apresentação do caso: I.P.M, masculino, 17 anos de idade, procurou o serviço do Hospital Geral de Goiás (HGG), referindo dor iniciada há 30 dias na face anterior do quadril esquerdo, durante partida de futebol. Refere aumento da intensidade da dor, e ao exame físico possui equimose local, edema e dor em quadril esquerdo. Ao raio x apresentou fratura da espinha ilíaca ântero superior à esquerda. Discussão: Essa lesão geralmente ocorre como resultado da contração súbita, vigorosa ou repetitiva do músculo sartório e tensor da fascia lata. Os sintomas mais comumente relatados são dor intensa associada a “estalos” na hemipelve afetada, edema, limitação funcional ipsilateral e equimoses. O tratamento é preferencialmente conservador, durando, em média, de 6 a 8 semanas. Já a cirurgia, é indicada para casos em que há desvio de mais de três centímetros ou com lesão neurovascular associada. Conclusão: Seu tratamento adequado, feito precocemente, torna-se importante na prevenção de lesões permanentes e complicações futuras. Na maioria das vezes, o tratamento e conservador, excetuando-se os casos de desvio fragmentário superior a três centímetros

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019 : a comprehensive demographic analysis for the Global Burden of Disease Study 2019

Background: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods: 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate age-specific fertility rates for 5-year age groups between ages 15 and 49 years. With extensions to age groups 10–14 and 50–54 years, the total fertility rate (TFR) was then aggregated using the estimated age-specific fertility between ages 10 and 54 years. 7417 sources were used for under-5 mortality estimation and 7355 for adult mortality. ST-GPR was used to synthesise data sources after correction for known biases. Adult mortality was measured as the probability of death between ages 15 and 60 years based on vital registration, sample registration, and sibling histories, and was also estimated using ST-GPR. HIV-free life tables were then estimated using estimates of under-5 and adult mortality rates using a relational model life table system created for GBD, which closely tracks observed age-specific mortality rates from complete vital registration when available. Independent estimates of HIV-specific mortality generated by an epidemiological analysis of HIV prevalence surveys and antenatal clinic serosurveillance and other sources were incorporated into the estimates in countries with large epidemics. Annual and single-year age estimates of net migration and population for each country and territory were generated using a Bayesian hierarchical cohort component model that analysed estimated age-specific fertility and mortality rates along with 1250 censuses and 747 population registry years. We classified location-years into seven categories on the basis of the natural rate of increase in population (calculated by subtracting the crude death rate from the crude birth rate) and the net migration rate. We computed healthy life expectancy (HALE) using years lived with disability (YLDs) per capita, life tables, and standard demographic methods. Uncertainty was propagated throughout the demographic estimation process, including fertility, mortality, and population, with 1000 draw-level estimates produced for each metric. Findings: The global TFR decreased from 2·72 (95% uncertainty interval [UI] 2·66–2·79) in 2000 to 2·31 (2·17–2·46) in 2019. Global annual livebirths increased from 134·5 million (131·5–137·8) in 2000 to a peak of 139·6 million (133·0–146·9) in 2016. Global livebirths then declined to 135·3 million (127·2–144·1) in 2019. Of the 204 countries and territories included in this study, in 2019, 102 had a TFR lower than 2·1, which is considered a good approximation of replacement-level fertility. All countries in sub-Saharan Africa had TFRs above replacement level in 2019 and accounted for 27·1% (95% UI 26·4–27·8) of global livebirths. Global life expectancy at birth increased from 67·2 years (95% UI 66·8–67·6) in 2000 to 73·5 years (72·8–74·3) in 2019. The total number of deaths increased from 50·7 million (49·5–51·9) in 2000 to 56·5 million (53·7–59·2) in 2019. Under-5 deaths declined from 9·6 million (9·1–10·3) in 2000 to 5·0 million (4·3–6·0) in 2019. Global population increased by 25·7%, from 6·2 billion (6·0–6·3) in 2000 to 7·7 billion (7·5–8·0) in 2019. In 2019, 34 countries had negative natural rates of increase; in 17 of these, the population declined because immigration was not sufficient to counteract the negative rate of decline. Globally, HALE increased from 58·6 years (56·1–60·8) in 2000 to 63·5 years (60·8–66·1) in 2019. HALE increased in 202 of 204 countries and territories between 2000 and 2019

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe